Wordt geladen...

Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those with obesity, type 2 diabetes (T2D) or cardiovascular diseases (CVD). Extra...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Obes Med
Hoofdauteurs: Pang, Juan, Liu, Mingyao, Ling, Wenhua, Jin, Tianru
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier Ltd. 2021
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7785422/
https://ncbi.nlm.nih.gov/pubmed/33426364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.obmed.2020.100312
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!